CGH
RGNX icon

Crossmark Global Holdings’s Regenxbio RGNX Stock Holding History

Crossmark Global Holdings’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,350
Closed -$392K – 1451
2021
Q3 		$392K Buy
9,350
+80
+0.9% +$2.88K 0.01% 1046
2021
Q2 		$360K Buy
9,270
+20
+0.2% +$715 0.01% 1085
2021
Q1 		$316K Buy
9,250
+360
+4% +$15.4K 0.01% 1140
2020
Q4 		$403K Buy
+8,890
New +$311K 0.01% 944
2019
Q3 		– Sell
-4,870
Closed -$250K – 1370
2019
Q2 		$250K Sell
4,870
-360
-7% -$18K 0.01% 1179
2019
Q1 		$300K Buy
5,230
+120
+2% +$5.94K 0.01% 1117
2018
Q4 		$214K Buy
5,110
+2,300
+82% +$135K 0.01% 1258
2018
Q3 		$212K Buy
+2,810
New +$202K 0.01% 1518

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return